Back

Evaluation of a new automated screening tool for the assessment of the eligibility for a subcutaneous implantable-cardioverter defibrillator

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Subcutaneous ICD Implantable Cardioverter / Defibrillator EHRA Premium Access EHRA 2018

About the speaker

Photo
Mr Rafi Sakhi

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

9 More presentations in this session

Presentation thumbnail
Eligibility of CRT Patients for Subcutaneous Implantable Cardioverter Defibrillators
Presentation thumbnail
Insight into screening results and post-implantation exercise testing in recipients of a subcutaneous Implantable cardioverter defibrillator
Doctor N. Dayal (Geneva, CH)
Abstract Slides
Presentation thumbnail
Universal S-ICD eligibility: eliminating the need for pre-implant screening using mathematical vector rotation and a gradient filter
Doctor B. Wiles (London, GB)
Abstract Slides
Presentation thumbnail
Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: a single center italian experience
Professor F. Migliore (Padova, IT)
Abstract Slides
Presentation thumbnail
Optimization of cardiac resynchronization therapy device selection guided by cardiac magnetic resonance imaging is cost-effective
Doctor M. Linhart (Barcelona, ES)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Subcutaneous ICD

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources